John C. Fortson was named Chief Financial Officer of DENTSPLY SIRONA Inc., effective July 20, 2026. As of November 6, 2026, DENTSPLY SIRONA Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 11, 2026, naming 1 appointment (Form 8-K, June 11, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like DENTSPLY SIRONA Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
DENTSPLY SIRONA Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-11. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as DENTSPLY SIRONA Inc. files it.
Also on the record for DENTSPLY SIRONA Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Southpoint Master Fund, LP | 3.5% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G, by AQR Capital Management, LLC | 5.22% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G/A, by First Eagle Investment Management, LLC | 0.4% of the class | 5%+ stakes | Source |
| July 8, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 12.6% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.27% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.36% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 18, 2026 | Stake report, Schedule 13G, by Southpoint Master Fund, LP | 5% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G, by Lazard Asset Management LLC | 4.4% of the class | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by AQR Capital Management, LLC | 2.45% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 0.1% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G, by AQR Capital Management, LLC | 6.68% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs DENTSPLY SIRONA Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on DENTSPLY SIRONA Inc. and the records around it.
DENTSPLY SIRONA Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Southpoint Master Fund, LP also filed stake reports on 2 other companies: Fennec Pharmaceuticals Inc. (Aug 2026), Ibotta, Inc. (Aug 2025)
- Lazard Asset Management LLC also filed stake reports on 14 other companies: Arcos Dorados Holdings Inc (Aug 2026), Brightstar Lottery PLC (Aug 2026), Morgan Stanley China A Share Fund Inc (Aug 2026)
- First Eagle Investment Management, LLC also filed stake reports on 16 other companies: AMTECH SYSTEMS INC (Aug 2026), Quanterix Corp (Aug 2026), Warrior Met Coal Inc (Aug 2026)
Watch DENTSPLY SIRONA Inc.
Get an email when DENTSPLY SIRONA Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on DENTSPLY SIRONA Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DENTSPLY SIRONA Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DENTSPLY SIRONA Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 13 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-11 | In | Chief Financial Officer | 2026-07-20 | 8-K, 2026-06-11 |
Who leads DENTSPLY SIRONA Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: John C. Fortson, appointed, effective 2026-07-20 (filed 2026-06-11).
New leaders reset buying decisions — get the Full Report on DENTSPLY SIRONA Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at DENTSPLY SIRONA Inc., with the record behind each one.
Find candidates like Chief Financial Officer at DENTSPLY SIRONA Inc.Every change, in the filing's words
Appointed: John C. Fortson, Chief Financial Officer, effective 2026-07-20
On June 1, 2026, the Board of Directors (the "Board") of DENTSPLY SIRONA Inc. (the "Company") appointed John C. Fortson as the Company's Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the "Effective Date").
- Mr. Fortson, age 58, currently serves as the President and Chief Financial Officer of Kymera International ("Kymera"), a global manufacturer of advanced performance materials and surface technologies.
- He has served as Chief Financial Officer, since March 2025, and began serving as President in April 2026.
- Prior to joining Kymera, Mr. Fortson served from 2020 to 2024 as President & Chief Executive Officer and as a member of the board of directors of Ingevity Corporation ("Ingevity"), a company that creates products and technologies including those relating to automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings.
- Mr. Fortson also served as Chief Financial Officer of Ingevity from 2015 to 2020.
- Mr. Fortson received his Bachelor of Science degree from the United States Military Academy at West Point and his Master of Business Administration degree from Duke University's Fuqua School of Business.
- The Company and Mr. Fortson have executed an offer letter pursuant to which Mr. Fortson will serve as the Company's Executive Vice President & Chief Financial Officer (the "Offer Letter").
Tools for this story
Each opens in a new tab, filled in for DENTSPLY SIRONA Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.